[go: up one dir, main page]

DK4071469T3 - Fremgangsmåder til analyse af kromatografidata - Google Patents

Fremgangsmåder til analyse af kromatografidata

Info

Publication number
DK4071469T3
DK4071469T3 DK22169905.1T DK22169905T DK4071469T3 DK 4071469 T3 DK4071469 T3 DK 4071469T3 DK 22169905 T DK22169905 T DK 22169905T DK 4071469 T3 DK4071469 T3 DK 4071469T3
Authority
DK
Denmark
Prior art keywords
analysis
methods
chromatography data
chromatography
data
Prior art date
Application number
DK22169905.1T
Other languages
English (en)
Inventor
Bernhard Schilling
Scott Carver
Stefanie Mcdermott
John Mattila
Hanne Bak
Nathan Mao
Eric Shierly
Original Assignee
Regeneron Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=60269959&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK4071469(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Regeneron Pharma filed Critical Regeneron Pharma
Application granted granted Critical
Publication of DK4071469T3 publication Critical patent/DK4071469T3/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/86—Signal analysis
    • G01N30/8603—Signal analysis with integration or differentiation
    • G01N30/8617—Filtering, e.g. Fourier filtering
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/86—Signal analysis
    • G01N30/8693—Models, e.g. prediction of retention times, method development and validation
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/88—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/88—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86
    • G01N2030/889—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 monitoring the quality of the stationary phase; column performance

Landscapes

  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Mathematical Physics (AREA)
  • Algebra (AREA)
  • Mathematical Analysis (AREA)
  • Mathematical Optimization (AREA)
  • Pure & Applied Mathematics (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
DK22169905.1T 2016-10-25 2017-10-25 Fremgangsmåder til analyse af kromatografidata DK4071469T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201662412563P 2016-10-25 2016-10-25
EP17795146.4A EP3532838B1 (en) 2016-10-25 2017-10-25 Methods and systems for chromatography data analysis

Publications (1)

Publication Number Publication Date
DK4071469T3 true DK4071469T3 (da) 2025-06-30

Family

ID=60269959

Family Applications (2)

Application Number Title Priority Date Filing Date
DK22169905.1T DK4071469T3 (da) 2016-10-25 2017-10-25 Fremgangsmåder til analyse af kromatografidata
DK17795146.4T DK3532838T3 (da) 2016-10-25 2017-10-25 Fremgangsmåder og systemer til kromatografidataanalyse

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK17795146.4T DK3532838T3 (da) 2016-10-25 2017-10-25 Fremgangsmåder og systemer til kromatografidataanalyse

Country Status (19)

Country Link
US (4) US10613063B2 (da)
EP (3) EP4575488A3 (da)
JP (4) JP7102401B2 (da)
KR (2) KR102564393B1 (da)
CN (3) CN109923411B (da)
AU (3) AU2017350807B2 (da)
BR (1) BR112019006689A2 (da)
CA (1) CA3039788A1 (da)
DK (2) DK4071469T3 (da)
EA (1) EA201990986A1 (da)
ES (2) ES3032778T3 (da)
FI (1) FI4071469T3 (da)
HU (2) HUE059631T2 (da)
IL (4) IL289895B (da)
MX (3) MX2019004316A (da)
PL (2) PL3532838T3 (da)
SG (1) SG11201902667UA (da)
WO (1) WO2018081203A1 (da)
ZA (1) ZA201902257B (da)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3454058A4 (en) * 2016-03-14 2020-02-26 Shimadzu Corporation MASS SPECTROMETRY DATA ANALYSIS AND PROGRAM FOR MASS SPECTROMETRY DATA ANALYSIS
ES3032778T3 (en) 2016-10-25 2025-07-24 Regeneron Pharma Methods for chromatography data analysis
WO2018098502A1 (en) * 2016-11-28 2018-05-31 Board Of Regents, The University Of Texas System Systems, methods and devices for width-based analysis of peak traces
US12018075B2 (en) * 2018-04-20 2024-06-25 Janssen Biotech, Inc. Chromatography column qualification in manufacturing methods for producing anti-TNF antibody compositions
CN109100441B (zh) * 2018-08-23 2021-05-07 西南科技大学 一种液相色谱曲线去除脉冲干扰的方法
JP6791216B2 (ja) * 2018-08-28 2020-11-25 横河電機株式会社 監視プログラム、監視装置、及び監視システム
GB201909274D0 (en) * 2019-06-27 2019-08-14 Ge Healthcare Bio Sciences Ab Method in bioprocess purification system
CN110988232A (zh) * 2019-11-28 2020-04-10 南通乐尔环保科技有限公司 一种色谱基线降噪方法及其装置
JP7452186B2 (ja) * 2020-03-30 2024-03-19 東ソー株式会社 クロマトグラフの運転状態の推定方法
CA3173338A1 (en) * 2020-04-14 2021-10-21 Eric Shierly Ultraviolet monitoring of chromatography performance by orthogonal partial least squares
JP2022091322A (ja) * 2020-12-09 2022-06-21 株式会社島津製作所 液体クロマトグラフのｐＨ管理システムおよびプログラム
US11157644B1 (en) * 2020-12-15 2021-10-26 DataMover LLC Systems and methods of secure networked data exchange
CN112730712B (zh) * 2020-12-31 2022-06-07 杭州谱育科技发展有限公司 提高lc-ms数据信噪比的方法
JP7647205B2 (ja) * 2021-03-17 2025-03-18 東ソー株式会社 精度管理機能を有する液体クロマトグラフィー装置
CN113321817A (zh) * 2021-07-06 2021-08-31 青岛科技大学 一种纳米木质素制备过程关键变量的分析方法
JP2024535429A (ja) * 2021-09-28 2024-09-30 メルク パテント ゲーエムベーハー 連続クロマトグラフィ動作中のクロマトグラフィ樹脂をモニタリングするための方法
JP7779170B2 (ja) * 2022-02-24 2025-12-03 株式会社島津製作所 クロマトグラフ分析装置及びクロマトグラフ分析用プログラム
CN115825313B (zh) * 2023-02-22 2023-04-11 华谱科仪(北京)科技有限公司 色谱信息检测方法、装置、电子设备和计算机可读介质
TW202528736A (zh) 2023-09-08 2025-07-16 美商再生元醫藥公司 用於評估層析管柱完整性的方法及系統

Family Cites Families (129)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5190864A (en) 1986-04-15 1993-03-02 Northeastern University Enzyme amplification by using free enzyme to release enzyme from an immobilized enzyme material
US4937188A (en) 1986-04-15 1990-06-26 Northeastern University Enzyme activity amplification method for increasing assay sensitivity
US4801726A (en) 1986-04-15 1989-01-31 Northeastern University Repetitive hit-and-run immunoassay and stable support-analyte conjugates; applied to T-2 toxin
JPH07111423B2 (ja) * 1986-10-01 1995-11-29 株式会社日立製作所 クロマトグラフのデ−タ処理方法
JPS6486060A (en) * 1987-09-29 1989-03-30 Shimadzu Corp Analysis data processor
US5412083A (en) 1992-04-16 1995-05-02 Northeastern University Carbohydrate heterobifunctional cross-linking reagent
US5429746A (en) 1994-02-22 1995-07-04 Smith Kline Beecham Corporation Antibody purification
WO1996025425A1 (en) 1995-02-16 1996-08-22 Massachusetts Health Research Institute, Inc. Purified tetanus toxoid and toxin
US5641870A (en) 1995-04-20 1997-06-24 Genentech, Inc. Low pH hydrophobic interaction chromatography for antibody purification
JP3180010B2 (ja) * 1995-10-13 2001-06-25 株式会社日立製作所 クロマトグラフ分析装置
KR19990056559A (ko) * 1997-12-29 1999-07-15 윤종용 노이즈 감소방법 및 그 장치
EP0964057B1 (en) 1998-05-11 2004-12-22 Tosoh Corporation Method for separating nucleic acids by means of liquid chromatography
US7070959B1 (en) 1999-06-08 2006-07-04 Regeneron Pharmaceuticals, Inc. Modified chimeric polypeptides with improved pharmacokinetic properties
US7306799B2 (en) 1999-06-08 2007-12-11 Regeneron Pharmaceuticals, Inc. Use of VEGF inhibitors for treatment of eye disorders
US7303746B2 (en) 1999-06-08 2007-12-04 Regeneron Pharmaceuticals, Inc. Methods of treating eye disorders with modified chimeric polypeptides
US7087411B2 (en) 1999-06-08 2006-08-08 Regeneron Pharmaceuticals, Inc. Fusion protein capable of binding VEGF
IL155002A0 (en) 2000-10-12 2003-10-31 Genentech Inc Reduced-viscosity concentrated protein formulations
US20020064860A1 (en) 2000-11-29 2002-05-30 Schering Corporation Method for purifying adenoviruses
US7101982B2 (en) 2001-03-30 2006-09-05 Immunex Corporation Control of ph transitions during chromatography
US6816789B2 (en) * 2001-04-19 2004-11-09 Varian, Inc. Method and system for analyzing chromatograms
WO2004020971A2 (en) 2002-08-28 2004-03-11 Introgen Therapeutics Inc. Chromatographic methods for adenovirus purification
DK1545574T3 (da) 2002-09-13 2014-09-08 Biogen Idec Inc Fremgangsmåde til rensning af polypeptider ved simuleret moving-bed-chromatografi
JPWO2004087761A1 (ja) 2003-03-31 2006-07-27 麒麟麦酒株式会社 ヒトモノクローナル抗体およびヒトポリクローナル抗体の精製
WO2005000898A2 (en) 2003-06-27 2005-01-06 Biogen Idec Ma Inc. Use of hydrophobic-interaction-chromatography or hinge-region modifications for the production of homogeneous antibody-solutions
ATE462716T1 (de) 2003-10-24 2010-04-15 Amgen Inc Verfahren zur aufreinigung von proteinen in einer durchflussfraktion aus der chromatographie mit hydrophoben wechselwirkungen
US8084032B2 (en) 2004-01-21 2011-12-27 Ajinomoto Co., Inc. Purification method which prevents denaturation of an antibody
SE0400501D0 (sv) 2004-02-27 2004-02-27 Amersham Biosciences Ab Antibody purification
WO2005082483A1 (en) 2004-02-27 2005-09-09 Ge Healthcare Bio-Sciences Ab A process for the purification of antibodies
SE0400886D0 (sv) 2004-04-02 2004-04-02 Amersham Biosciences Ab Process of purification
US20060027454A1 (en) 2004-08-09 2006-02-09 Dinovo Augustine Procedure for the fractionation of proteins by using sequential ion exchange and hydrophobic interaction chromatography as prefractionation steps before analysis by two dimensional electrophoresis
US7795405B2 (en) 2004-08-09 2010-09-14 Guild Associates, Inc. Procedure for the fractionation of proteins by using sequential ion exchange and hydrophobic interaction chromatography as prefractionation steps before analysis by two dimensional electrophoresis
WO2006043895A1 (en) 2004-10-21 2006-04-27 Ge Healthcare Bio-Sciences Ab A method of antibody purification
CA2621047A1 (en) 2005-02-02 2006-08-24 Regeneron Pharmaceuticals, Inc. Method of treating eye injury with local administration of a vegf inhibitor
US20080299671A1 (en) 2005-12-02 2008-12-04 Ge Healthcare Bio-Sciences Ab Hydrophobic Interaction Chromatography
RU2008142359A (ru) 2006-03-28 2010-05-10 Ф.Хоффманн-Ля Рош Аг (Ch) Композиция человеческого моноклонального антитела к igf-1r
EP2738178A1 (en) 2006-04-05 2014-06-04 AbbVie Biotechnology Ltd Antibody purification
SI2944306T1 (sl) 2006-06-16 2021-04-30 Regeneron Pharmaceuticals, Inc. Formulacije antagonista VEGF, primerne za intravitrealno dajanje
WO2008028974A1 (en) 2006-09-08 2008-03-13 Novo Nordisk A/S Methods of optimizing chromatographic separation of polypeptides
JP2010505874A (ja) 2006-10-03 2010-02-25 ノヴォ ノルディスク アー／エス ポリペプチドコンジュゲートの精製方法
WO2008109721A1 (en) 2007-03-06 2008-09-12 Introgen Therapeutics, Inc. Chromatographic methods for assessing adenovirus purity
US8003364B2 (en) 2007-05-14 2011-08-23 Bavarian Nordic A/S Purification of vaccinia viruses using hydrophobic interaction chromatography
WO2009058769A1 (en) 2007-10-30 2009-05-07 Schering Corporation Purification of antibodies containing hydrophobic variants
US8568586B2 (en) * 2008-01-25 2013-10-29 Biogen Idec Ma Inc. Automated system and method for monitoring chromatography column performance, and applications thereof
US7897405B2 (en) * 2008-02-11 2011-03-01 Thermo Finnigan Llc Method for identifying the elution time of an analyte
US20090277254A1 (en) * 2008-05-09 2009-11-12 Medlmmune, Llc Methods of improving packed-bed chromatography performance
DK2338049T3 (da) * 2008-08-15 2021-03-01 Biogen Ma Inc Fremgangsmåder til evaluering af en kromatografisøjles ydeevne
US20100069617A1 (en) 2008-09-12 2010-03-18 Ge Healthcare Bio-Sciences Ab Enhanced protein aggregate removal by mixed mode chromatography on hydrophobic interaction media in the presence of protein-excluded zwitterions
NZ592097A (en) 2008-10-20 2013-01-25 Abbott Lab Viral inactivation during purification of il-12 and il-18 antibodies
KR20110091678A (ko) 2008-10-20 2011-08-12 아보트 러보러터리즈 단백질 ａ 친화성 크로마토그래피를 이용한 항체의 분리 및 정제
NZ613809A (en) 2009-05-04 2015-02-27 Abbvie Biotechnology Ltd Stable high protein concentration formulations of human anti-tnf-alpha-antibodies
CN102803478B (zh) 2009-06-16 2016-04-27 建新公司 用于纯化重组aav载体的改进方法
US8821879B2 (en) 2009-09-04 2014-09-02 Xoma Technology Ltd. Anti-botulism antibody coformulations
PL3037104T3 (pl) 2009-10-20 2020-11-16 Abbvie Inc. Izolacja i oczyszczanie przeciwciał anty-il-13 z zastosowaniem chromatografii powinowactwa z białkiem a
US8246833B2 (en) 2009-12-17 2012-08-21 Ge Healthcare Bio-Sciences Ab Chromatography column and maintenance method
EA201201132A1 (ru) 2010-02-12 2013-03-29 ДСМ АйПи АССЕТС Б.В. Очистка антител с помощью единого функционального блока
US9773090B2 (en) * 2010-06-10 2017-09-26 International Business Machines Corporation Method computer program and system to analyze mass spectra
WO2012030512A1 (en) 2010-09-03 2012-03-08 Percivia Llc. Flow-through protein purification process
MX344727B (es) 2010-11-11 2017-01-05 Abbvie Biotechnology Ltd Formulaciones liquidas de anticuerpos anti-tnf-alfa de alta concentracion mejoradas.
SG191186A1 (en) 2010-12-15 2013-07-31 Baxter Int Eluate collection using conductivity gradient
US20120246211A1 (en) * 2011-03-24 2012-09-27 Lytle Fred E Syntactical system and method for chromatographic peak identification
HUP1100312A2 (en) * 2011-06-14 2013-01-28 Emil Dr Mincsovics Procedure and equipment for improving of performance characteristics of column chromatography separation processes
TWI589299B (zh) 2011-10-11 2017-07-01 再生元醫藥公司 用於治療類風濕性關節炎之組成物及其使用方法
US9943594B2 (en) 2011-10-11 2018-04-17 Sanofi Biotechnology Methods for the treatment of rheumatoid arthritis
EP2773439A4 (en) 2011-10-31 2015-07-01 Merck Sharp & Dohme CHROMATOGRAPHY METHOD FOR RESOLVING HETEROGENIC ANTIBODY AGGREGATES
US8871209B2 (en) 2011-11-14 2014-10-28 Regeneron Pharmaceuticals, Inc. Compositions and methods for increasing muscle mass and muscle strength by specifically antagonizing GDF8 and or Activin A
AU2012340826A1 (en) 2011-11-21 2014-05-29 Genentech, Inc. Purification of anti-c-met antibodies
JP6092892B2 (ja) 2011-12-15 2017-03-08 プレステージ バイオファーマ プライベート リミテッド 抗体の精製方法
JP6077568B2 (ja) * 2012-01-16 2017-02-08 レコ コーポレイションＬｅｃｏ Ｃｏｒｐｏｒａｔｉｏｎ クロマトグラフィーシステムでのデータを処理するためのシステム及び方法
WO2013158273A1 (en) 2012-04-20 2013-10-24 Abbvie Inc. Methods to modulate c-terminal lysine variant distribution
US9067990B2 (en) 2013-03-14 2015-06-30 Abbvie, Inc. Protein purification using displacement chromatography
WO2013158279A1 (en) 2012-04-20 2013-10-24 Abbvie Inc. Protein purification methods to reduce acidic species
US20130336957A1 (en) 2012-05-21 2013-12-19 Abbvie, Inc. Novel purification of human, humanized, or chimeric antibodies using protein a affinity chromatography
US20140154270A1 (en) 2012-05-21 2014-06-05 Chen Wang Purification of non-human antibodies using kosmotropic salt enhanced protein a affinity chromatography
WO2013176754A1 (en) 2012-05-24 2013-11-28 Abbvie Inc. Novel purification of antibodies using hydrophobic interaction chromatography
US8941405B2 (en) 2012-08-03 2015-01-27 International Business Machines Corporation FET pair based physically unclonable function (PUF) circuit with a constant common mode voltage
EP2879691B1 (en) 2012-08-06 2019-03-27 Biogen MA Inc. Methods for inactivating enveloped viruses
US9650411B2 (en) 2012-08-07 2017-05-16 Kyowa Hakko Kirin Co., Ltd. Method of purifying protein
JP6326066B2 (ja) 2012-12-20 2018-05-16 メディミューン，エルエルシー 凝集プロファイルが改善されている液状抗体製剤
HK1219964A1 (zh) 2013-03-08 2017-04-21 Genzyme Corporation 治疗性蛋白药物物质的整合连续制造
CA2905010A1 (en) 2013-03-12 2014-09-18 Abbvie Inc. Human antibodies that bind human tnf-alpha and methods of preparing the same
US10023608B1 (en) 2013-03-13 2018-07-17 Amgen Inc. Protein purification methods to remove impurities
CA2926384A1 (en) 2013-03-14 2014-10-02 Abbvie Inc. Low acidic species compositions and methods for producing and using the same
US9017687B1 (en) 2013-10-18 2015-04-28 Abbvie, Inc. Low acidic species compositions and methods for producing and using the same using displacement chromatography
ES2834113T3 (es) 2013-03-15 2021-06-16 H Lundbeck As Purificación de anticuerpos y monitorización de la pureza
PL2970378T3 (pl) 2013-03-15 2021-12-06 Biogen Ma Inc. Chromatografia oddziaływań hydrofobowych białek w warunkach bez soli
CA2911514A1 (en) 2013-05-06 2014-11-13 Scholar Rock, Inc. Compositions and methods for growth factor modulation
US10111953B2 (en) 2013-05-30 2018-10-30 Regeneron Pharmaceuticals, Inc. Methods for reducing remnant cholesterol and other lipoprotein fractions by administering an inhibitor of proprotein convertase subtilisin kexin-9 (PCSK9)
TWI682780B (zh) 2013-05-30 2020-01-21 美商再生元醫藥公司 醫藥組成物用於製造治療與ｐｃｓｋ９功能獲得性突變有關之體染色體顯性高膽固醇血症的藥物之用途
TWI633891B (zh) 2013-06-04 2018-09-01 再生元醫藥公司 藉由投與ｉｌ－４ｒ抑制劑以治療過敏及增強過敏原－特異之免疫療法的方法
KR101569783B1 (ko) 2013-06-05 2015-11-19 한화케미칼 주식회사 항체의 정제 방법
US9150938B2 (en) 2013-06-12 2015-10-06 Orochem Technologies, Inc. Tagatose production from deproteinized whey and purification by continuous chromatography
AR096713A1 (es) 2013-06-25 2016-01-27 Cadila Healthcare Ltd Proceso de purificación para anticuerpos monoclonales
EP3041593B1 (en) 2013-09-05 2025-01-29 F. Hoffmann-La Roche AG Method of cleaning a chromatography material for its reuse
BR112016004437A2 (pt) 2013-09-13 2017-10-17 Genentech Inc métodos de imunoteste e de seleção de linhagem de células, anticorpos e kit
CN105722532A (zh) 2013-09-13 2016-06-29 豪夫迈·罗氏有限公司 包含纯化的重组多肽的方法和组合物
US8946395B1 (en) 2013-10-18 2015-02-03 Abbvie Inc. Purification of proteins using hydrophobic interaction chromatography
WO2015061526A1 (en) 2013-10-25 2015-04-30 Medimmune, Llc Antibody purification
US10115576B2 (en) * 2013-12-12 2018-10-30 Waters Technologies Corporation Method and an apparatus for analyzing a complex sample
CN103616458B (zh) * 2013-12-14 2015-05-27 环境保护部南京环境科学研究所 一种定量检测大气细粒子pm2.5中6种硝基苯类化合物的方法
JP6260351B2 (ja) * 2014-03-04 2018-01-17 株式会社島津製作所 クロマトグラフ用データ処理装置及びデータ処理方法
JO3701B1 (ar) 2014-05-23 2021-01-31 Regeneron Pharma مضادات حيوية بشرية لمتلازمة الشرق الأوسط التنفسية - بروتين كورونا فيروس الشوكي
FR3025515B1 (fr) 2014-09-05 2016-09-09 Lab Francais Du Fractionnement Procede de purification d'un anticorps monoclonal
TW201628649A (zh) 2014-10-09 2016-08-16 再生元醫藥公司 減少醫藥調配物中微可見顆粒之方法
WO2016089886A2 (en) 2014-12-02 2016-06-09 Regeneron Pharmaceuticals, Inc. Methods for treating dry eye disease by administering an il-6r antagonist
WO2016118707A1 (en) 2015-01-21 2016-07-28 Oncobiologics, Inc. Modulation of charge variants in a monoclonal antibody composition
TWI710573B (zh) 2015-01-26 2020-11-21 美商再生元醫藥公司 抗伊波拉病毒醣蛋白之人類抗體
CN104748764B (zh) * 2015-04-01 2017-05-24 清华大学 一种声场可视化系统中声像平面的空间角度标定方法
TWI756187B (zh) 2015-10-09 2022-03-01 美商再生元醫藥公司 抗ｌａｇ３抗體及其用途
SI3394103T1 (sl) 2015-12-22 2023-10-30 Regeneron Pharmaceuticals, Inc. Kombinacija protiteles proti-PD-1 in bispecifičnih protiteles proti-CD20/proti-CD3 za zdravljenje raka
CA3009322A1 (en) 2015-12-22 2017-06-29 Regeneron Pharmaceuticals, Inc. Bispecific anti-cd20/anti-cd3 antibodies to treat acute lymphoblastic leukemia
EP3184119A1 (en) 2015-12-23 2017-06-28 Themis Bioscience GmbH Chromatography based purification strategies for measles scaffold based viruses
GB201602938D0 (en) 2016-02-19 2016-04-06 Ucb Biopharma Sprl Protein purification
US10353868B2 (en) * 2016-04-11 2019-07-16 RMC Pharmaceutical Solutions, Inc. Methods and systems for event based notifications
CN109641928B (zh) 2016-06-14 2022-08-30 比奥根Ma公司 用于寡核苷酸纯化的疏水性相互作用色谱法
WO2018027195A1 (en) 2016-08-05 2018-02-08 Abbvie Biotherapeutics Inc. Compositions containing reduced amounts of daclizumab acidic isoforms and methods for preparing the same
ES3032778T3 (en) * 2016-10-25 2025-07-24 Regeneron Pharma Methods for chromatography data analysis
US10626376B2 (en) 2016-11-14 2020-04-21 St. Jude Children's Research Hospital Method for isolating and purifying adeno-associated virus particles using salt
US11697670B2 (en) 2017-08-22 2023-07-11 Biogen Ma Inc. Methods for purifying antibodies having reduced high molecular weight aggregates
JP7462566B2 (ja) 2018-03-16 2024-04-05 ブリストル－マイヤーズ スクイブ カンパニー タンパク質生産の間の代謝酵素活性およびジスルフィド結合還元
WO2019178495A1 (en) 2018-03-16 2019-09-19 Biogen Ma Inc. Methods for purifying recombinant adeno-associated viruses
KR20200136464A (ko) 2018-03-29 2020-12-07 브리스톨-마이어스 스큅 컴퍼니 단량체성 모노클로날 항체를 정제하는 방법
EP3810650A1 (en) 2018-06-19 2021-04-28 Bristol-Myers Squibb Company Methods of purifying proteins using chromatography
TW202448568A (zh) 2018-07-02 2024-12-16 美商里珍納龍藥品有限公司 自混合物製備多肽之系統及方法
EP3826743A4 (en) 2018-07-25 2022-09-14 Merck Sharp & Dohme Corp. METHODS FOR SEPARATION OF HOST CELL LIPASES FROM A PRODUCTION PROTEIN IN CHROMATOGRAPHIC METHODS
KR20250099418A (ko) 2018-08-15 2025-07-01 브리스톨-마이어스 스큅 컴퍼니 하류 크로마토그래피에서의 재산화에 의한 단백질 단편화 제어 전략
WO2020096958A1 (en) 2018-11-05 2020-05-14 Bristol-Myers Squibb Company Method for purifying pegylated protein
US20220135619A1 (en) 2019-02-24 2022-05-05 Bristol-Myers Squibb Company Methods of isolating a protein
JP7570344B2 (ja) 2019-03-29 2024-10-21 ブリストル－マイヤーズ スクイブ カンパニー クロマトグラフィー樹脂の疎水性を測定する方法
JP7539420B2 (ja) 2019-06-28 2024-08-23 武田薬品工業株式会社 アデノ随伴ウイルスの精製方法

Also Published As

Publication number Publication date
EA201990986A1 (ru) 2019-09-30
PL3532838T3 (pl) 2022-10-03
FI4071469T3 (fi) 2025-07-17
HUE072096T2 (hu) 2025-10-28
IL295211B1 (en) 2024-05-01
EP4575488A2 (en) 2025-06-25
IL295211A (en) 2022-10-01
EP3532838A1 (en) 2019-09-04
KR102564393B1 (ko) 2023-08-08
EP3532838B1 (en) 2022-06-01
PL4071469T3 (pl) 2025-07-28
JP2024028600A (ja) 2024-03-04
JP7102401B2 (ja) 2022-07-19
MX2023009744A (es) 2023-08-30
AU2022246438B2 (en) 2024-12-12
MX2023009743A (es) 2023-08-30
AU2022246438A1 (en) 2022-11-03
SG11201902667UA (en) 2019-05-30
CN114858957A (zh) 2022-08-05
BR112019006689A2 (pt) 2019-06-25
IL289895A (en) 2022-03-01
CN119492842A (zh) 2025-02-21
JP2025161934A (ja) 2025-10-24
US11680930B2 (en) 2023-06-20
US20200191756A1 (en) 2020-06-18
DK3532838T3 (da) 2022-07-04
ES3032778T3 (en) 2025-07-24
AU2017350807B2 (en) 2022-07-07
AU2024266951A1 (en) 2024-12-19
HUE059631T2 (hu) 2022-12-28
US10613063B2 (en) 2020-04-07
CN109923411A (zh) 2019-06-21
IL265874B (en) 2022-02-01
JP2020500299A (ja) 2020-01-09
EP4071469A3 (en) 2022-12-14
JP7734769B2 (ja) 2025-09-05
IL265874A (en) 2019-06-30
US20230273163A1 (en) 2023-08-31
CA3039788A1 (en) 2018-05-03
IL289895B (en) 2022-09-01
KR20230119729A (ko) 2023-08-16
EP4575488A3 (en) 2025-08-20
ES2924060T3 (es) 2022-10-04
EP4071469A2 (en) 2022-10-12
KR102759512B1 (ko) 2025-02-03
IL312194A (en) 2024-06-01
CN109923411B (zh) 2022-05-31
KR20190073396A (ko) 2019-06-26
WO2018081203A1 (en) 2018-05-03
JP7427721B2 (ja) 2024-02-05
JP2022125254A (ja) 2022-08-26
IL295211B2 (en) 2024-09-01
MX2019004316A (es) 2019-08-05
US20180113101A1 (en) 2018-04-26
CN114858957B (zh) 2024-11-22
ZA201902257B (en) 2020-11-25
US20220308025A1 (en) 2022-09-29
AU2017350807A1 (en) 2019-04-18
US11333642B2 (en) 2022-05-17
EP4071469B1 (en) 2025-04-09

Similar Documents

Publication Publication Date Title
DK4071469T3 (da) Fremgangsmåder til analyse af kromatografidata
DK3548652T3 (da) Fremgangsmåder til proteinanalyse
EP3449438A4 (en) Customer experience analytics
DK3673493T3 (da) Brugerflade til analyse af elektrokardiogrammer
DK3077943T3 (da) Fremgangsmåder og systemer til analyse af billeddata
EP3323070A4 (en) Neo-antigen-ANALYSIS
DK3882357T3 (da) Fremgangsmåder og sammensætninger til analyse af nukleinsyrer
DK3110975T3 (da) Fremgangsmåder til analyse af somatiske mobile elementer og anvendelser deraf
DK3538864T3 (da) Mikrotom
DK3452695T3 (da) Fremgangsmåder og systemer til analyse af hydrauliskfrakturerede reservoirer
DK3497207T3 (da) Fremgangsmåder til påvisning af aav
DK3563156T3 (da) Fremgangsmåde til separering af biomolekyler
DK3194612T3 (da) Fremgangsmåder til kvantitativ genetisk analyse af cellefrit dna
DK3436998T3 (da) Instrument til overvågning af en analytkoncentration
DK3171765T3 (da) Indsamling og analyse af data til diagnostiske formål
DK3792378T3 (da) Fremgangsmåder og anordninger til analyse af partikler
DK3384274T3 (da) Fremgangsmåder til prøvekarakterisering
DK3665173T3 (da) Ny fremgangsmåde til yntetisering af amanitiner
DK3265583T3 (da) Fremgangsmåde til påvisning af aviær nekrotisk enteritis
DK3487443T3 (da) Fremgangsmåde til opmåling af en implantat-implantat-situation
DK3237636T3 (da) Dobbelt-quenching analyse til multiplex detektion af målnukleinsyrer
DK3822365T3 (da) Platform til opdagelse og analyse af terapeutiske midler
EP3358346A4 (en) PROCESS FOR ENANTIOMER ANALYSIS
DK3563155T3 (da) Præfabrikeret mikropartikel til udførelse af en påvisning af en analyt
DK3366832T3 (da) Indretning til identifikation af stoftype